|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-2-12
|
|
pubmed:abstractText |
We evaluated the effect of direct angiogenesis inhibition in synovium of patients with rheumatoid arthritis (RA), using a soluble vascular endothelial growth factor receptor 1 (VEGFR1) chimeric protein.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
240-5
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11838840-Angiogenesis Inhibitors,
pubmed-meshheading:11838840-Arthritis, Rheumatoid,
pubmed-meshheading:11838840-Cells, Cultured,
pubmed-meshheading:11838840-Coculture Techniques,
pubmed-meshheading:11838840-Dose-Response Relationship, Drug,
pubmed-meshheading:11838840-Endothelium, Vascular,
pubmed-meshheading:11838840-Humans,
pubmed-meshheading:11838840-Immunoenzyme Techniques,
pubmed-meshheading:11838840-Neovascularization, Pathologic,
pubmed-meshheading:11838840-Proto-Oncogene Proteins,
pubmed-meshheading:11838840-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:11838840-Recombinant Fusion Proteins,
pubmed-meshheading:11838840-Stromal Cells,
pubmed-meshheading:11838840-Synovial Membrane,
pubmed-meshheading:11838840-Vascular Endothelial Growth Factor Receptor-1
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein.
|
|
pubmed:affiliation |
Department of Orthopedic Surgery, Miyazaki Medical College, Kiyotake, Japan. sekkin@kaiju.medic.kumamoto-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
